76075-07-5

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl N-formyl-N-benzylglycinate is used as an antimicrobial agent for its ability to inhibit the growth of bacteria and fungi, making it suitable for various medicinal applications.
Used in Cosmetic Industry:
Ethyl N-formyl-N-benzylglycinate is used as a preservative in cosmetic products due to its ability to prevent microbial contamination, ensuring product safety and longevity.
Used in Fragrance Production:
Ethyl N-formyl-N-benzylglycinate is used as a starting material in the synthesis of various organic compounds, contributing to the creation of unique fragrances for consumer goods.
Used in Chemical Manufacturing:
Ethyl N-formyl-N-benzylglycinate serves as an important intermediate in chemical manufacturing processes, playing a crucial role in the synthesis of a wide range of organic compounds.

InChI:InChI=1/C12H15NO3/c1-2-16-12(15)9-13(10-14)8-11-6-4-3-5-7-11/h3-7,10H,2,8-9H2,1H3

Upstream product

• 64-18-6 formic acid 
• 6436-90-4 ethyl 2-(benzylamino)acetate 
• 100-46-9 benzylamine 

Downstream Products

• 501428-67-7 2-(benzyl-formyl-amino)-3-oxo-propionic acid ethyl ester 
• 76075-21-3 ethyl 1-benzyl-1H-imidazole-5-carboxylic acid 
• 76075-15-5 methyl 1-benzyl-2-mercaptoimidazole-5-carboxylate 

Relevant academic research and scientific papers

Novel nonprostanoid prostacyclin (PGI2) mimetics with heterocyclic moiety

Structural modification of [2-(2-benzhydryloxyiminopentyl)-1,2,3,4-tetrahydro-5-naphthyloxy]acetic acid (4), previously identified as a PGI2 agonist without a PG skeleton, was examined. Conversion of the oxime moiety in 4 to the pyrazole led to [2-(4-benzhydrylpylazoyl)methyl-1,2,3,4-tetrahydro-5-naphthyloxy]acetic acid (34) which strongly inhibited ADP-induced aggregation of human platelets in vitro.

Imidazole derivatives with potential biological activity

A series of 1-substituted imidazole-5-carbohydroxamic acids Ia, Ib and Ie were prepared from the corresponding 5-methoxycarbonyl imidazoles (IX) obtained by a univocal synthesis starting with the reaction of the amines (III) with ethylchloroacetate. On treatment of 4(5)-methoxycarbonyl imidazoles (XI) with alkylar halides (X), on the contrary, mixtures of 1-substituted-4(or 5)-methoxycarbonyl imidazoles were obtained that, when separated by thin-layer chromatography, gave the carbohydroxamic acids Ia, Ib, Id and Ie and IIa→f. The structures of the imidazole derivatives were obtained by means of IR, NMR and UV spectra. On carrying out tests of biological activity on these compounds, it had been found that the 5-carbohydroxamic acids possess, compared to the 4-carbohydroxamic ones, a greater activity. Particularly Ib and Ib-HCl seem fairly active against Klebsiella pneumoniae and Clostridium bifermentans, Ib-HCl against Bacillus subtilis, too.